Navigation Links
Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease

FORT LEE, N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Neurologix, Inc. (OTCBB:NRGX) today announced the publication in the June 23 issue of the journal The Lancet of positive results from the first ever gene therapy trial for Parkinson's disease and the first report of direct gene transfer into a patient's own brain cells for any adult neurodegenerative disease.

The open label Phase 1 study, conducted in 12 patients with advanced Parkinson's disease demonstrated both a lack of adverse events related to the gene therapy procedure and statistically significant improvements from baseline in both clinical symptoms and abnormal brain metabolism (as measured by positron emission tomography, or PET scanning). Although all patients had symptoms on both sides of the body, the procedure was performed on only one side of the brain, enabling the untreated side to serve as a study control. The reported improvements were observed primarily on the treated side of the body beginning three months after the gene therapy procedure and persisted through the 12 months formal study period.

Neurologix sponsored the study as part of its ongoing efforts to develop this and other gene therapy approaches to the treatment of neurodegenerative and metabolic diseases. Principal investigators Michael G. Kaplitt, MD, PhD, and Matthew J. During, MD, PhD, performed the procedures at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Andrew Feigin, MD and David Eidelberg, MD of the Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System performed the clinical evaluations and the PET scans. Neurologix scientists were also co-investigators in the study.

"This ground-breaking study represents not only an encouraging first step in the development of a promising new approach to Parkinson's disease therapy, but also provides a platform to translate a variety of new gene therapy agents into human clinical
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:5/6/2015)... CVS Health (NYSE: CVS ) officially announced today that it ... sustained heavy fire damage during protests last week.  "As ... over the past week or so, our hearts turned from pain ... and CEO Larry Merlo . "Our purpose as a company ... no better way that we can fulfill that purpose than to ...
(Date:5/6/2015)... May 6, 2015 Saint-Gobain has ... manufacture of filtration products, mainly for the life sciences ... filters manufactured in a state-of-the-art plant in ... sold across the globe and will bolster the range ... This acquisition is fully in line with the ...
(Date:5/6/2015)... May 06, 2015 Research and Markets ... of the "Cannulas Market by Product (Nasal, ... Venous, Microcannula), Material (Plastic, Metal) & End Users ... 2020" report to their offering. ... at a CAGR of 5.6% from 2015 to ...
Breaking Medicine Technology:CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Saint-Gobain Acquires ZenPure, a Specialist in Filtration Products 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 2Global Cannulas Market 2015 - Forecasts to 2020 with Medtronic, Edward Lifesciences, Terumo, Sorin & Maquet Holding B.V. & Co. Dominating 3
... 8 Globus Medical, Inc., the largest,privately held ... recognized,leader in motion preservation technology, today announced the ... IDE study. The,SECURE(R)-C device is designed to mimic ... alleviate pain and restore function as an alternative ...
... potential of asenapine in the treatment of ... schizophrenia and bipolar I disorder, ... announced that an overview of asenapine clinical trials,from the Olympia ... Psychiatric Association in Washington, D.C., May 3-8. Data from,the studies, ...
Cached Medicine Technology:Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7
(Date:5/6/2015)... Anitoa Systems, (“Anitoa”), a Palo Alto startup established ... successfully demonstrated a handheld real time quantitative-polymerase-chain-reaction system (qPCR) ... qPCR is shown to be capable of detecting several ... C, and E. Coli. This qPCR system has achieved ... 9 orders of magnitude dynamic range. A key ...
(Date:5/6/2015)... California (PRWEB) May 06, 2015 In March, ... presenting at the 8th Milano Masterclass. As Europe’s most ... most elite plastic surgeons. Dr. Batniji was hand chosen ... Facial Plastic and Reconstructive Surgery, Dr. Pietro Palma. ... Milan, Italy. The conference hosts a diverse, multi-national faculty; ...
(Date:5/6/2015)... Manassas, VA (PRWEB) May 06, 2015 Locally ... Oil, LLC, was recognized this past week as having one ... The company’s EVOO, imported from the Peloponnese region of Greece ... Gold Award in the category of Medium Olive Oil, ... EVOO for everyday use”. With over 700 producer applicants ...
(Date:5/6/2015)... May 06, 2015 The Alliance ... the regenerative medicine and advanced therapies community, today ... report, offering an in-depth look at sector trends ... 2015. , The report is available online ... key data points, available here . , ...
(Date:5/6/2015)... Water NSW (New South Wales) in ... distribute imagery, LiDAR, and Elevation Data within the organisation. ... on earth, and the need to ensure a reliable ... rainfalls has driven the development of several complex and ... water supplies for NSW, including high quality drinking water ...
Breaking Medicine News(10 mins):Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3Health News:California Surgeon Speaks at International Rhinoplasty Conference 2Health News:Greek Extra Virgin Olive Oil, Laconiko Wins Gold at the NYIOOC and Is Featured in Olive Oil Times as One of Greece's Best EVOO's for 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 3
... 10-Sessions for Permanent Weight LossNEW YORK, March 10 ... called The Caryl Ehrlich Program, and it is changing ... countless diets, The Program teaches participants one-on-one 10 behavioral ... lose weight and keep it off forever.The Program focuses ...
... March 10 Availity, LLC, the industry,s ... promotion of Russ Thomas to President and ... is playing a major role in health ... exchange platform to advance health quality and ...
... Race Provides $3.7 Million Impact on D.C. Breast HealthWASHINGTON, March ... the leaders of Susan G. Komen for the Cure(R) joined ... States, at the Italian Embassy to officially kick off registration ... for the Cure(R), which will be held on the Washington, ...
... been named vice president and chief nursing officer ... nation,s leading providers of end-of-life care. In her ... interdisciplinary clinical teams delivering patient care at all ... was senior director of operations compliance for VITAS, ...
... Vaccine Guarantor Selects Sparta Systems, Software to Meet ... N.J., March 10 Sparta Systems, Inc., the ... software, today announced that Netherlands Vaccine Institute (NVI), ... vaccines against infectious diseases for the Dutch population, ...
... -- The standard Prostate Specific Antigen (PSA) test for ... slow-growing forms. At the Annual EAU Congress, which will ... Stockholm (SE), Dr. Arun Sreekumar - University of Michigan ... that can supposedly discriminate between aggressive and non-aggressive prostate ...
Cached Medicine News:Health News:Behavioral Approach to Weight Loss 2Health News:Availity Promotes Russ Thomas to President and Chief Operating Officer 2Health News:D.C. Mayor Fenty, Italian Ambassador Help Announce First-Ever Susan G. Komen Global Race for the Cure(R) 2Health News:D.C. Mayor Fenty, Italian Ambassador Help Announce First-Ever Susan G. Komen Global Race for the Cure(R) 3Health News:D.C. Mayor Fenty, Italian Ambassador Help Announce First-Ever Susan G. Komen Global Race for the Cure(R) 4Health News:VITAS Innovative Hospice Care(R) Names Karen Peterson Vice President and Chief Nursing Officer 2Health News:Netherlands Vaccine Institute Chooses TrackWise(R) Solution for Enterprise-wide Compliance with Good Manufacturing Practices 2Health News:Netherlands Vaccine Institute Chooses TrackWise(R) Solution for Enterprise-wide Compliance with Good Manufacturing Practices 3Health News:Netherlands Vaccine Institute Chooses TrackWise(R) Solution for Enterprise-wide Compliance with Good Manufacturing Practices 4Health News:Dr. Arun Sreekumar lectures on new candidate biomarker at Annual EAU Congress 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: